H&H International Holdings(01112.HK): Total revenue for 2025 recorded a low double-digit increase year-over-year

Gelonghui, March 3 — H&H International Holdings (01112.HK) announced that for the fiscal year ending December 31, 2025, the group’s total revenue increased by a low double-digit percentage compared to last year on a reporting and peer comparison basis. This strong growth was mainly driven by all business segments, including adult nutrition and care products, infant nutrition and care products, and pet nutrition and care products.

For the fiscal year ending December 31, 2025, the adult nutrition and care products segment saw revenue grow by a mid-single-digit percentage, primarily driven by low double-digit growth in Mainland China and continued robust double-digit growth in other expanding markets. This excellent performance was mainly due to the sustained strong growth of innovative product categories such as heart health, anti-aging, and detoxification, as well as the continued growth of the Swisse Plus and Little Swisse series. Although the group strategically prioritized reducing the corporate purchasing agent business, resulting in a double-digit decline in overall revenue from Australia and New Zealand (“ANZ”), domestic market revenue in ANZ achieved a mid-single-digit increase, outperforming the overall domestic market.

For the fiscal year ending December 31, 2025, revenue from the infant nutrition and care products segment rebounded with a strong double-digit increase. Sales of infant formula milk powder in this segment grew strongly by a double-digit percentage year-over-year, significantly surpassing the overall infant formula milk powder market in China. This notable increase reflects the successful transition to the new “national standard” and the effective and strict implementation of strategic development focus, including expanding coverage to new mothers through social media, e-commerce platforms, and dedicated infant stores.

For the fiscal year ending December 31, 2025, revenue from infant probiotics and nutritional supplements increased by a low single-digit percentage year-over-year. The recovery to positive growth was driven by the successful launch of innovative probiotic products and the accelerated growth of infant stores and online channels. The revenue increase was also attributed to the expansion of product portfolios such as children’s nutritional powder supplements.

For the fiscal year ending December 31, 2025, leveraging favorable structural advantages and global trends toward high-end and humanized pet products, pet nutrition and care products achieved high single-digit percentage growth on a peer comparison basis. The high-margin pet supplement category continued to record steady double-digit revenue growth.